| Molecular profiling reveals prognostically significant subtypes of canine lymphoma AM Frantz, AL Sarver, D Ito, TL Phang, A Karimpour-Fard, MC Scott, ... Veterinary pathology 50 (4), 693-703, 2013 | 134 | 2013 |
| Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study CA London, LF Bernabe, S Barnard, WC Kisseberth, A Borgatti, ... PloS one 9 (2), e87585, 2014 | 109 | 2014 |
| Impact of toceranib/piroxicam/cyclophosphamide maintenance therapy on outcome of dogs with appendicular osteosarcoma following amputation and carboplatin chemotherapy: a multi … CA London, HL Gardner, T Mathie, N Stingle, R Portela, ML Pennell, ... PLoS One 10 (4), e0124889, 2015 | 82 | 2015 |
| Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma AB Jeffreys, DW Knapp, WW Carlton, RM Thomas, PL Bonney, ... Journal of the American Animal Hospital Association 41 (4), 221-226, 2005 | 58 | 2005 |
| A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma SE Fritz, MS Henson, E Greengard, AL Winter, KM Stuebner, U Yoon, ... Veterinary medicine and science 2 (3), 179-190, 2016 | 56 | 2016 |
| Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells D Dhawan, AB Jeffreys, R Zheng, JC Stewart, DW Knapp Molecular Cancer Therapeutics 7 (4), 897-904, 2008 | 56 | 2008 |
| Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma C Cannon, A Borgatti, M Henson, B Husbands Journal of small animal practice 56 (7), 425-429, 2015 | 54 | 2015 |
| Safe and effective sarcoma therapy through bispecific targeting of EGFR and uPAR A Borgatti, JS Koopmeiners, AL Sarver, AL Winter, K Stuebner, ... Molecular cancer therapeutics 16 (5), 956-965, 2017 | 49 | 2017 |
| Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The … A Flory, KM Kruglyak, JA Tynan, LM McLennan, JM Rafalko, PC Fiaux, ... PLoS One 17 (4), e0266623, 2022 | 44 | 2022 |
| Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma AR Sadowski, HL Gardner, A Borgatti, H Wilson, DM Vail, J Lachowicz, ... BMC veterinary research 14, 1-7, 2018 | 42 | 2018 |
| Adjuvant sirolimus does not improve outcome in pet dogs receiving standard-of-care therapy for appendicular osteosarcoma: a prospective, randomized trial of 324 dogs AK LeBlanc, CN Mazcko, A Cherukuri, EP Berger, WC Kisseberth, ... Clinical Cancer Research 27 (11), 3005-3016, 2021 | 39 | 2021 |
| A tumor‐related lymphoid progenitor population supports hierarchical tumor organization in canine B‐cell lymphoma D Ito, MM Endicott, CM Jubala, KM Helm, RC Burnett, BD Husbands, ... Journal of veterinary internal medicine 25 (4), 890-896, 2011 | 38 | 2011 |
| A comparative oncology study of iniparib defines its pharmacokinetic profile and biological activity in a naturally-occurring canine cancer model C Saba, M Paoloni, C Mazcko, W Kisseberth, JH Burton, A Smith, ... PLoS One 11 (2), e0149194, 2016 | 29 | 2016 |
| Phase I clinical trial of the use of zinc phthalocyanine tetrasulfonate as a photosensitizer for photodynamic therapy in dogs A Borgatti-Jeffreys, SB Hooser, MA Miller, MD Lucroy American journal of veterinary research 68 (4), 399-404, 2007 | 29 | 2007 |
| Clinical signs, treatment, and outcome in cats with myeloma-related disorder receiving systemic therapy CM Cannon, C Knudson, A Borgatti ?? Journal Title?? 51 (4), 239-248, 2015 | 24 | 2015 |
| Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors K Pilbeam, H Wang, E Taras, RJ Bergerson, B Ettestad, T DeFor, ... Oncotarget 9 (15), 11938, 2017 | 23 | 2017 |
| Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic … A Borgatti, AL Winter, K Stuebner, R Scott, CP Ober, KL Anderson, ... PLoS One 12 (2), e0172651, 2017 | 22 | 2017 |
| Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma AR Masyr, AK Rendahl, AL Winter, A Borgatti, JF Modiano Journal of the American Veterinary Medical Association 258 (6), 630-637, 2021 | 18 | 2021 |
| Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin F Oh, D Todhunter, E Taras, DA Vallera, A Borgatti Clinical pharmacology: advances and applications, 113-121, 2018 | 18 | 2018 |
| Plasma cell tumors A Borgatti Schalm's veterinary hematology, 588-598, 2022 | 14 | 2022 |
